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Author Correction: SREBP1 drives keratin-80-
dependent cytoskeletal changes and invasive
behavior in endocrine-resistant ERα breast cancer
Ylenia Perone 1,14, Aaron J. Farrugia2,14, Alba Rodríguez-Meira1,12,14, Balázs Győrffy3,4, Charlotte Ion1,
Andrea Uggetti5, Antonios Chronopoulos6, Pasquale Marrazzo 7, Monica Faronato8, Sami Shousha9,
Claire Davies10, Jennifer H. Steel 10, Naina Patel10, Armando del Rio Hernandez 6, Charles Coombes1,
Giancarlo Pruneri11, Adrian Lim1, Fernando Calvo2,13 & Luca Magnani 1
Correction to: Nature Communications https://doi.org/10.1038/s41467-019-09676-y, published online 9 May 2019.
This Article contained an error in the name of the author Alba Rodríguez-Meira, which was incorrectly given as Alba Rodríguez Meira.
These errors have been corrected in the PDF and HTML versions of the article.
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